![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW BIOTECHNOLOGICAL AND PHARMACOLOGICAL DEVELOPMENTS IN THE MODIFICATION OF CHRONIC INFLAMMATION-INDUCED DISEASES Free access
Minerva Biotechnology and Biomolecular Research 2021 June;33(2):65-75
DOI: 10.23736/S2724-542X.21.02766-X
Copyright © 2021 EDIZIONI MINERVA MEDICA
language: English
Vitamin D in the prevention and treatment of type-2 diabetes and associated diseases: a critical view during COVID-19 time
Tetyana FALALYEYEVA 1 ✉, Iuliia KOMISARENKO 2, Andrii YANCHYSHYN 3, Oleksandr KOVALCHUK 1, 3, Yuliia LOZKO 3, Olena TSYRYUK 1, Sharmila FAGOONEE 4, Nazarii KOBYLIAK 2, 5
1 Educational and Scientific Center Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; 2 Department of Endocrinology, Bogomolets National Medical University, Kyiv, Ukraine; 3 Department of Descriptive and Clinical Anatomy, Bogomolets National Medical University, Kyiv, Ukraine; 4 Institute of Biostructures and Bioimaging (CNR) c/o Molecular Biotechnology Center, Turin, Italy; 5 Laboratory of Pathology CSD Health Care, Kyiv, Ukraine
Vitamin D deficiency has been recognized as a pandemic with many negative health consequences in many countries. Today the mechanisms of anti-inflammatory and hepatoprotective action of vitamin D
KEY WORDS: Vitamin D; Diabetes mellitus, type 2; Non-alcoholic fatty liver disease